company

OSTOMYCURE AS

0250 OSLO

Return on Equity
219,94 %
Current Ratio
0,25
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue0
Net Income−14 518 000
Total Assets23 274 000
Total Equity−6 601 000
Income (NOK)2022
Revenue0
Expenditure13 404 000
Operating Profit−13 404 000
Financial Income141 000
Financial Costs1 255 000
Financial Balance−1 114 000
Earnings Before Tax−14 518 000
Tax0
Net Income−14 518 000
Balance (NOK)2022
Total Fixed Assets15 680 000
Total Current Assets7 594 000
Total Assets23 274 000
Total Retained Equity−22 395 000
Total Equity−6 601 000
Total Long-Term Debt0
Total Current Debt29 875 000
Total Equity and Debt23 274 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure13 404 000
Operating Profit−13 404 000
Financial Income141 000
Financial Costs1 255 000
Financial Balance−1 114 000
Dividends0
Net Income−14 518 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets15 680 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets15 680 000
Stock0
Total Investments0
Cash, Bank5 367 000
Total Current Assets7 594 000
Total Assets23 274 000
Total Equity−6 601 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 457 000
Unpaid Taxes0
Dividends0
Other Current Debt12 276 000
Total Current Debt29 875 000
Total Equity and Debt23 274 000
Financial indicators2022
Return on Equity219,94 %
Debt-to-Equity Ratio−0
Operating Profit Margin-
Current Ratio0,25
Quick Ratio0,25
Equity Ratio−0,28
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English